Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region)
© Mirrakhimov et al; licensee BioMed Central Ltd. 2012
Received: 5 December 2011
Accepted: 22 February 2012
Published: 22 February 2012
People of different racial and ethnic backgrounds have a distinct pattern of central fat deposition, thus making it necessary to devise a race based approach for the diagnosis and evaluation of abdominal obesity (AO). This is the first study to determine the optimal waist circumference (WC) cutoff values for definition of AO in an ethnic Kyrgyz population.
323 persons of Kyrgyz ethnicity (183 women and 140 men), with a mean age of 51.8 ± 9.5 years old were included in the study. Measurement of blood pressure (BP), anthropometric data (including body mass index calculation and WC measurement), fasting blood sugar, serum lipid parameters and insulin were performed in all examined individuals. Insulin resistance (IR) was considered as HOMA index (insulin × fasting glucose/22.5) ≥ 2.77. Sensitivity and specificity for the presence of IR or two other criteria of MS (according to the international classification, 2009) were calculated by using receiver operating characteristic (ROC) curves for men and women separately.
The optimal sensitivity and specificity obtained from the ROC curves for IR were 88 cm in women (sensitivity of 0.85, 95%CI (0.72-0.93), specificity of 0.58, 95%CI (0.49-0.66)) and 94 cm for men (sensitivity of 0.8, 95% CI (0.65-0.91), specificity of 0.61, 95% CI (0.51-0.71)). The data from the ROC curve for any two other MS criteria confirmed the results and the WC 88 cm in women (sensitivity of 0.82, 95% CI (0.72-0.9), specificity of 0.72, 95% CI (0.62-0.8)) and 94 cm in men (sensitivity of 0.74, 95% CI (0.62-0.84), specificity of 0.73, 95% CI (0.61-0.83)) were corresponded to the optimal sensitivity and specificity.
WC ≥ 88 cm and ≥ 94 cm should be used as a criterion for the diagnosis of AO for Kyrgyz women and men respectively based on these results.
KeywordsObesity Abdominal obesity Waist circumference insulin resistance Metabolic syndrome Cardiovascular risk
Metabolic syndrome (MS) is a particularly common medical condition consisting of abdominal obesity (AO), arterial hypertension, as well as disturbances in lipid and/or carbohydrate metabolism. The presence of MS increases cardiovascular morbidity and mortality and risk of future type 2 diabetes mellitus (DM) [1, 2]. Obesity is believed to be a core pathologic stimulus for the development of hyperinsulinemia and insulin resistance (IR), which are predictive for the development of new onset type 2 DM . Obesity is also associated with increased cardiovascular risk, but with age this association seems to fade .
Several clinical approaches for MS diagnosis are currently available such as, Adult Treatment Panel (ATP III) of the National Cholesterol Education Program  and its modified version  use waist circumference (WC) of ≥88 cm and ≥102 cm for the diagnosis of AO in women and men respectively. Since ATP III clinical criteria are best suitable for North American population, and the fact that people of Asian origin have higher abdominal fat with the same body mass index (BMI) as well as a greater risk for the new onset type 2 DM with the same BMI values and this approach may underestimate metabolic risk among Asians . Dong and colleagues have found the greater accuracy of height to weight ratio for the diagnosis of MS compared to traditional measurement of WC in a Chinese population . Interestingly, Park and colleagues have demonstrated that Asians with BMI < 27 kg/m2 have higher predictive power of epicardial fat for the presence of MS and coronary artery disease, which may indirectly support the notion of distinct pattern of adiposity among Asians .
The controversies of current clinical models for diagnosing MS were highlighted in the secondary analysis of the FIELD study . The researchers compared three different criteria for MS: World Health Organization, ATP III and International Diabetes Federation. They have concluded that WHO MS criteria can identify patients with DM who have a lower risk of future cardiovascular events.
There are some misconceptions regarding the optimal WC values and methods of assessing this in some Asian populations [11, 12]. A recent Joint Interim Statement on MS proposes that WC ≥80 cm and ≥90 cm are diagnostic for AO in Asian women and men respectively . However such generalization may be wrong due to possible heterogeneities among Asian populations. Thus, the need for different diagnostic criteria based on ethnic background was critically needed.
The information about optimal WC values for MS diagnosis was not known for the Kyrgyz ethnic group, and this became a cardinal impetus for the study.
323 individuals (183 females, 140 males) 30-80 years (mean age 51.8 ± 9.5 years) from the general population were included in the study. Informed consent was signed prior to enrollment. Exclusion criteria: pregnancy, concomitant thyroid disease, heart failure, chronic kidney and liver disease, insulin therapy and chronic alcohol addiction.
Systolic and diastolic blood pressure (SBP and DBP respectively) measurements, anthropometric assessment such as weight, height were measured in all study participants. WC was measured in the standing relaxed position, during expiration, at the midline between the lower costal margins and the iliac crest parallel to the floor. Body mass index (BMI) was calculated as a weight (kg) to height (m2) ratio.
General characteristics of studies population
Study participants (n - 323)
51.8 ± 9.5
AH; n (%)
SBP: mm Hg
135.2 ± 21.8
DBP; mm Hg
85.5 ± 12.5
Obesity (BMI ≥ 30 kg/m2); n (%)
27.5 ± 4.8
91.7 ± 11.5
Smoking; n (%)
Positive family history for CVD; n (%)
Type 2 DM; n (%)
Fasting glucose; mmol/l
5.92 ± 1.83
Insulin resistance; n (%)
Serum insulin; μIU/ml*
CHD; n (%)
5.12 ± 1.11
1.14 ± 0.34
3.27 ± 0.96
Blood collection from the cubital vein took place after 12 h of fasting in the morning, with further separation to the plasma and serum, which were frozen in liquid nitrogen. Subsequently laboratory tests such as fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and immunoreactive insulin levels were analyzed from the frozen blood samples. Low density lipoprotein cholesterol (LDL- C) was calculated by Friedwald W. formula . Homeostasis model of assessment (HOMA) was used as a surrogate marker of IR and calculated as serum insulin (μIU/ml) × plasma glucose (mmol/l)/22.5. HOMA index ≥2.77 was considered to be diagnostic for IR, according to the results from the Bruneck study .
The "Microsoft-Statistica 8.0" and "Graph Pad PRIZM 5" software were used for statistical analyses. ANOVA according to Kruskal-Wallis method was used to compare the IR values (given the nonparametric distribution of variables). A posthoc comparison of variables was measured by the Mann-Whitney test with Bonferroni correction. Odds ratio (OR) and 95% confidence interval (CI) were calculated using the "2 × 2 tables" in the "Graph Pad PRIZM 5" program. Receiver-Operating Characteristic (ROC) analysis was performed with the construction of ROC curves to identify the borderline WC values. Variables are present as mean ± standard deviation for normal distribution and median (25%-75%) for variables with nonparametric distribution. The p value < 0.05 was used as a cut off for statistical significance.
To define the threshold values for WC, the entire data set (separately for men and women) was divided into sub-groups with WC increments of 4-5 cm. Common borderline values from the modified ATP III criteria (≥ 102 cm in men and ≥88 cm in women), the International diabetes Federation (IDF) criteria (≥94 cm in men and ≥80 cm in women) and the IDF criteria for the Asian population (≥ 90 cm in men and ≥80 cm in women) were taken into consideration. Thus, women were subdivided based on the WC values into subgroups of < 80 cm, 80-87 cm, and ≥88 cm; and men were subdivided into these subgroups < 90 cm, 90- 93 cm, 94-101 cm, ≥102 cm.
After this, each subgroup was analyzed for the presence of IR, blood insulin concentration, the HOMA index and the OR of having IR. A greater WC was associated with an increased likelihood for IR in both women and men. Women with WC ≥88 cm had 2.5 times increased prevalence of IR compared to the WC of 80-87 cm. 23% of men with WC ≥90 cm had IR, whereas 28% of men with WC of 94-101 cm had IR. 60% of men with WC ≥ 102 cm had IR, which was expected. However statistical significance was observed only for the subgroup with WC of 94-101 cm.
The gradual statistically significant increase of HOMA index and blood insulin concentration was found in association with the increase in WC for all groups. Neither men nor women experienced jumps in HOMA index or insulin concentration.
IR indexes according to WC in women
IR; n (%)
OR (95% CI)
< 80 (n-41)
7.05(0.8-61.6) P1-2 = 0.057
26 (3.4-19.5) P1-3 < 0.0001 P2-3 < 0.005
IR indexes according to WC in men
IR; n (%)
OR (95% CI)
< 90 (n-44)
6.56 (1.15-3.73) P1-2 < 0.01
8.4 (1.7-4.15) P1-3 < 0.003
24 (60) *#£
31.5 (6.66-14.9) P1-4 < 0.0001 P2-4001 P3-4 < 0.005
Current clinical guidelines do not include IR as the MS criteria. Therefore, we also conducted ROC analysis to identify the threshold WC values, which increase the risk for detection of any two other MS criteria (BP ≥ 130/85 mm Hg, fasting blood sugar ≥ 5,6 mmol/l, HDL-C in men < 1.03 mmol/l and in women < 1.29 mmol/l, TG 1.7 mmol/l).
The data regarding the definition of AO based on ethnic and racial guidelines is controversial. US Caucasians have increased cardiovascular risk with WC ≥102 cm and ≥88 cm for men and women respectively. Whereat, African Americans have borderline WC of 89 to 109 cm for men and from 83 to 105 cm for women respectively, due to a lower amount of visceral fat with the same BMI [16–18]. Since African Americans have a higher prevalence of cardiovascular risk factors it was believed to use a similar WC cut off. The similar conclusions were made for indigenous American population .
The same is true regarding borderline WC values for Europeans. Accordingly to some studies, the risk of new onset type 2 DM development increases from WC ≥94 cm and ≥ 80 cm in men and women respectively [20–22].
In India, where type 2 DM and IR are highly prevalent [24, 25], the researchers have found that the risk of type 2 DM started to rise from BMI > 23 kg/m2 and WC > 85 cm in men and WC > 80 in women [26, 27]. The optimal WC values of ≥85 cm for men and ≥80 cm for women of Chinese descent were found after pooling the results of 13 population studies .
Similar studies were performed in Japan where borderline WC values of 85 to 90 cm for men and > 80 cm for women were found . In an ethnic Korean population, the borderline WC ranges from 85 to 90 cm in men and from 80 to 85 cm in women [30–32]. The borderline WC values of 99.5 cm for men and 94.3 cm were found for Iranians aged 19-65 years .
Controversies on the optimal definition of the AO according to the racial and ethnic background are still present. Our data may be extrapolated on nearby Central Asian indigenous groups, such as Kazakhs, Uzbeks and Turkmens and help to resolve some of the current difficulties in this area. Nevertheless studies with a larger population sample are critically needed to find the optimal definition for AO in Central Asian population groups. This approach can significantly increase the accuracy for the diagnosis of AO, which is a key criterion for the diagnosis of MS. Thus it can potentially decrease the healthcare burden of this disease through appropriate lifestyle and medical intervention in a proper time.
This is the first study to determine the optimal WC cut off values for an ethnic Kyrgyz population. WC ≥ 88 cm and ≥94 cm should be used as a criterion for the diagnosis of AO for Kyrgyz women and men respectively based on these results.
Adult treatment panel
Body mass index
Diastolic blood pressure
Fasting plasma glucose
High density lipoprotein cholesterol
Homeostasis model of assessment
International diabetes federation
Low density lipoprotein cholesterol
Receiver operating characteristic
Systolic blood pressure
- Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpussalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.View ArticlePubMed
- Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Folsom AR, Chambless LE: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 2005, 28: 2013-2018. 10.2337/diacare.28.8.2013.View ArticlePubMed
- Sung KC, Seo MH, Rhee EJ, Wilson AM: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol. 2011, 10: 108-10.1186/1475-2840-10-108.PubMed CentralView ArticlePubMed
- Wakabayashi I, Daimon T: Receiver-operated characteristics (ROCs) of the relationships between obesity indices and multiple risk factors (MRFs) for atherosclerosis at different ages in men and women. Arch Gerontol Geriatr. 2011.
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and reatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421.
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Curr Opin Cardiol. 2006, 21: 1-6. 10.1097/01.hco.0000200416.65370.a0.View ArticlePubMed
- Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.View ArticlePubMed
- Dong X, Liu Y, Yang J, Sun Y, Chen L: Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population. Postgrad Med J. 2011, 87: 251-256. 10.1136/pgmj.2010.100453.View ArticlePubMed
- Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH: Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol. 2010, 9: 29-10.1186/1475-2840-9-29.PubMed CentralView ArticlePubMed
- Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC: Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol. 2011, 10 (1): 102-10.1186/1475-2840-10-102.PubMed CentralView ArticlePubMed
- Yokoyama H, Hirose H, Kanda T, Kawabe H, Saito I: Relationship between waist circumferences measured at the umbilical level and midway between the ribs and iliac crest - a solution to the debate on optimal waist circumference standards in the diagnostic criteria of metabolic syndrome in Japan. J Atheroscler Thromb. 2011, 18: 735-743. 10.5551/jat.7369.View ArticlePubMed
- Das M, Pal S, Ghosh A: Prevalence of the metabolic syndrome in people of Asian Indian origin: outcomes by definitions. Cardiovasc J Afr. 2011, 22: 303-305. 10.5830/CVJA-2010-070.View ArticlePubMed
- Alberti MM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KI: Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the Association for the Study of Obesity Heart Federation; International Atherosclerosis Society; and International National Heart, Lung, and Blood Institute; American Heart Association; World International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.View ArticlePubMed
- Fridewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
- Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998, 47: 1643-1649. 10.2337/diabetes.47.10.1643.View ArticlePubMed
- Deurenberg P, Yap M, van Staveren WA: Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998, 22: 1164-1171. 10.1038/sj.ijo.0800741.View ArticlePubMed
- Diaz VA, Mainous AG, Baker R, Carnemolla M, Majeed A: How does ethnicity affect the association between obesity and diabetes?. Diabet Med. 2007, 24 (11): 1199-1204. 10.1111/j.1464-5491.2007.02244.x.View ArticlePubMed
- Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S: Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr. 2005, 81: 409-415.PubMed
- Lear SA, James PT, Ko GT, Kumanyika S: Appropriateness of waist circumference and waist-to- hip ratio cutoffs for different ethnic groups. Eur J Clin Nutr. 2010, 64: 42-61. 10.1038/ejcn.2009.70.View ArticlePubMed
- Lean J, Han TS, Morrison CE: Waist circumference as a measure for indicating need for weight management. BMJ. 1995, 311 (6998): 158-161. 10.1136/bmj.311.6998.158.PubMed CentralView ArticlePubMed
- Lean J, Han TS, Seidell JC: Impairment of health and quality of life in people with large waist circumference. Lancet. 1998, 351 (9106): 853-856. 10.1016/S0140-6736(97)10004-6.View ArticlePubMed
- Han TS, van Leer EM, Seidell JC, Lean J: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995, 311 (7017): 1401-1405. 10.1136/bmj.311.7017.1401.PubMed CentralView ArticlePubMed
- World Health Organization: Obesity: Preventing and Managing the Global Epidemic: Report on a WHO Consultation (WHO Technical Report Series 894. 2000, Geneva, Switzerland: World Health Organization
- Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999, 84: 137-144. 10.1210/jc.84.1.137.PubMed
- Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM: Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999, 84: 2329-2335. 10.1210/jc.84.7.2329.PubMed
- Snehalatha C, Viswanathan V, Ramachandran A: Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults. Diabetes Care. 2003, 26 (5): 1380-1384. 10.2337/diacare.26.5.1380.View ArticlePubMed
- Mohan V, Deepa M, Farooq S, Narayan KM, Datta M, Deepa R: Anthropometric cut points for identification of cardiometabolic risk factors in an urban Asian Indian population. Metabolism. 2007, 56 (7): 961-968. 10.1016/j.metabol.2007.02.009.View ArticlePubMed
- Zhou BF: Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002, 15: 83-96.PubMed
- Examination Committee of Criteria for "Obesity Disease" in Japan; Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Circ J. 2002, 66 (11): 987-992. 10.1253/circj.66.987.
- Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ: Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007, 75: 72-80. 10.1016/j.diabres.2006.04.013.View ArticlePubMed
- Koh JH, Koh SB, Lee MY, Jung PM, Kim BH, Shin JY: Optimal Waist Circumference Cutoff Values for Metabolic Syndrome Diagnostic Criteria in a Korean Rural Population. J Korean Med Sci. 2010, 25: 734-737. 10.3346/jkms.2010.25.5.734.PubMed CentralView ArticlePubMed
- Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY: Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study. Yonsei Med J. 2010, 51 (4): 511-518. 10.3349/ymj.2010.51.4.511.PubMed CentralView ArticlePubMed
- Heshmat R, Khashayar P, Meybodi HR, Homami MR, Larijani B: The appropriate waist circumference cut-off for Iranian population. Acta Med Indones. 2010, 42 (4): 209-215.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.